Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SF3A2P1, or Splicing factor 3a subunit 2 pseudogene 1, is a pseudogene related to the functional SF3A2 gene, which encodes a subunit of the splicing factor 3a protein complex. SF3A2P1 does not produce a functional protein product and is not involved in pre-mRNA splicing or other biological processes attributable to SF3A2. As a pseudogene, SF3A2P1 is generally considered transcriptionally inactive and is not regarded as a therapeutic target, disease gene, or biomarker. If you are seeking information on the functional gene (SF3A2), note that SF3A2 (not SF3A2P1) encodes a component of the spliceosome involved in pre-mRNA splicing, and it has reported roles in cell cycle regulation and disease[1][2][3]. But SF3A2P1 is a pseudogene—not a protein-coding gene, enzyme, receptor, or established therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Splicing factor 3a subunit 2 pseudogene 1 (SF3A2P1).